Thomas Andrew Davis Insider Trading $CLDX Celldex Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas Andrew Davis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas Andrew Davis. Thomas Andrew Davis is Executive VP & CMO in Celldex Therapeutics, Inc. ($AVAN) and Chief Medical Officer in GENVEC INC ($GNVC) and CHIEF MEDICAL OFFICER in GENOCEA BIOSCIENCES, INC. ($GNCA).
Thomas Andrew Davis in Celldex Therapeutics, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Thomas Andrew Davis: Executive VP & CMO
Holdings: 0 shares
Latest Transaction: Jun 16 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Thomas Andrew Davis in Celldex Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CLDX, GNCA, GNVC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2017 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Executive VP & CMO | Option Exercise | A | 2.32 | 150,000 | 348,000 | 150,000 | |
| Jun 09 2016 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Executive VP & CMO | Option Exercise | A | 4.72 | 157,000 | 741,040 | 157,000 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Executive VP & CMO | Option Exercise | A | 25.41 | 116,500 | 2,960,265 | 116,500 |
Page: 1